Glutathione
L-Glutathione (GSH, reduced)
Master antioxidant for detoxification and skin health
About
A tripeptide of cysteine, glutamine, and glycine that serves as the body's most abundant endogenous antioxidant. Produced in every cell, glutathione neutralizes reactive oxygen species, recycles vitamins C and E, and supports phase II liver detoxification. Available as oral capsules, liposomal preparations, sublingual lozenges, subcutaneous injection, and intravenous infusion. Best-studied human effect is modest, reversible skin lightening; injectable use carries notable safety concerns and is not FDA-approved.
Mechanism
Donates electrons via its cysteine thiol to neutralize free radicals, then is recycled by glutathione reductase. Inhibits the melanin-producing enzyme tyrosinase, shifting eumelanin synthesis toward lighter pheomelanin. Cofactor for glutathione peroxidase and glutathione-S-transferase detoxification pathways.
Dosage
Draw to 150000 units on a U-100 insulin syringe
1,200 mg lyophilized · 3.0 mL bacteriostatic water BAC
When to take: Empty stomach is traditional but not proven necessary. Injectable doses morning or early afternoon. Stack with NAC and vitamin C to support endogenous regeneration.
Reconstitution
Vial size (mg): 1,200 mg lyophilized · BAC water (mL): 3.0 mL bacteriostatic water · Concentration: 400 mg/mL
Some products ship as ready-to-inject solution (no reconstitution needed). Inject water down vial wall and swirl gently — do not shake.
Benefits
- Modest, reversible skin lightening in sun-exposed areas
- Supports liver detoxification and phase II conjugation
- Replenishes systemic antioxidant capacity
- May improve NAFLD liver enzyme markers in small trials
- Reduces oxidative stress biomarkers
Side effects
- Oral: bloating, loose stools, mild cramping
- IV: flushing, dizziness, rare anaphylaxis
- Injectable: risk of endotoxin contamination (FDA warning 2019)
- Sulfur smell on breath or skin
- Rare acute liver injury reported with IV use
Gender notes
Cautions
- Pregnancy and breastfeeding
- Asthma (inhaled forms may trigger bronchospasm)
- G6PD deficiency, especially with high-dose IV vitamin C
- Active sulfa allergy (caution)
- Concurrent chemotherapy without oncology approval
Research
- Oral glutathione supplementation impacts skin pigmentation: a randomised double-blind placebo-controlled trial
Journal of Dermatological Treatment · 2017
Oral 500 mg/day for 4 weeks significantly reduced melanin indices in sun-exposed skin versus placebo.
- The clinical effect of glutathione on skin color and other related skin conditions: a systematic review
Journal of Cosmetic Dermatology · 2019
Review of RCTs finds inconsistent but trending evidence for skin brightening; oral forms safer than IV.
- Systemic glutathione as a skin-whitening agent in adult individuals
Dermatologic Therapy · 2020
Narrative review of dose-response and safety profile across oral, sublingual, and intravenous routes.